Defence Therapeutics Inc.
DTCFF
$0.60
-$0.03-5.11%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 903.60K | 1.45M | 90.70K | 97.10K | 41.30K |
| Total Receivables | 145.20K | 61.10K | 31.90K | 24.40K | 70.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.50K | 3.00K | 11.80K | 24.60K | 44.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.07M | 1.51M | 134.40K | 146.10K | 156.50K |
|
|
|||||
| Total Current Assets | 1.07M | 1.51M | 134.40K | 146.10K | 156.50K |
| Net Property, Plant & Equipment | 137.60K | 133.50K | 145.70K | 168.20K | 192.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.21M | 1.64M | 280.10K | 314.40K | 349.10K |
|
|
|||||
| Total Accounts Payable | 976.60K | 802.40K | 1.56M | 1.62M | 1.53M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 10.90K | 34.60K | 36.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.10M | 968.80K | 881.50K | 1.33M | 1.23M |
| Total Finance Division Other Current Liabilities | 52.20K | 26.10K | 226.20K | 384.10K | 164.30K |
| Total Other Current Liabilities | 52.20K | 26.10K | 226.20K | 384.10K | 164.30K |
| Total Current Liabilities | 2.13M | 1.80M | 2.68M | 3.36M | 2.96M |
|
|
|||||
| Total Current Liabilities | 2.13M | 1.80M | 2.68M | 3.36M | 2.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 10.90K | 34.60K | 36.80K |
| Capital Leases | -- | -- | -- | -- | 5.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.13M | 1.80M | 2.68M | 3.36M | 2.97M |
|
|
|||||
| Common Stock & APIC | 17.74M | 13.87M | 14.07M | 14.24M | 14.06M |
| Retained Earnings | -21.49M | -19.70M | -19.51M | -22.49M | -21.78M |
| Treasury Stock & Other | 2.83M | 5.68M | 3.04M | 5.20M | 5.10M |
| Total Common Equity | -920.80K | -152.90K | -2.40M | -3.05M | -2.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -920.80K | -152.90K | -2.40M | -3.05M | -2.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -920.80K | -152.90K | -2.40M | -3.05M | -2.62M |
|
|
|||||